FORTE BIOSCIENCES, INC. Proceeds from Stock Options Exercised
FORTE BIOSCIENCES, INC. (FBRX) reported Proceeds from Stock Options Exercised of $22.50 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromStockOptionsExercised · last filed 2026-08-12
- FORTE BIOSCIENCES, INC. proceeds from stock options exercised for the quarter ending 2021-12-31 was $1.00K.
- FORTE BIOSCIENCES, INC. proceeds from stock options exercised for the quarter ending 2021-09-30 was $19.00K, a 88.55% decline year-over-year.
- FORTE BIOSCIENCES, INC. proceeds from stock options exercised for the quarter ending 2021-06-30 was $15.00K, a 68.09% decline year-over-year.
- FORTE BIOSCIENCES, INC. proceeds from stock options exercised for the quarter ending 2021-03-31 was $27.00K, a 40.00% decline year-over-year.
- FORTE BIOSCIENCES, INC. proceeds from stock options exercised for fiscal 2021 was $62.00K, a 75.88% decline from fiscal 2020.
- FORTE BIOSCIENCES, INC. proceeds from stock options exercised for fiscal 2020 was $257.00K, a 1.98% increase from fiscal 2019.
- FORTE BIOSCIENCES, INC. proceeds from stock options exercised for fiscal 2019 was $252.00K, a 276.12% increase from fiscal 2018.
- FORTE BIOSCIENCES, INC. proceeds from stock options exercised for fiscal 2018 was $67.00K, a 17.28% decline from fiscal 2017.
| Period end | Proceeds from Stock Options Exercised 3 month | Proceeds from Stock Options Exercised 6 month | Proceeds from Stock Options Exercised 9 month | Proceeds from Stock Options Exercised 12 month |
|---|---|---|---|---|
| 2026-06-30 | $22.50M 10-Q · filed 2026-08-12 | |||
| 2025-06-30 | $0.00 10-Q · filed 2026-08-12 | |||
| 2021-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $20.00K derived: sum of 2 quarters · filed 2022-03-31 | $35.00K derived: sum of 3 quarters · filed 2022-03-31 | $62.00K 10-K · filed 2022-03-31 |
| 2021-09-30 | $19.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | $34.00K derived: sum of 2 quarters · filed 2021-11-08 | $61.00K 10-Q · filed 2021-11-08 | $60.00K derived: sum of 4 quarters · filed 2022-03-31 |
| 2021-06-30 | $15.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | $42.00K 10-Q · filed 2021-08-16 | $41.00K derived: sum of 3 quarters · filed 2022-03-31 | $207.00K derived: sum of 4 quarters · filed 2022-03-31 |
| 2021-03-31 | $27.00K 10-Q · filed 2021-05-10 | $26.00K derived: sum of 2 quarters · filed 2022-03-31 | $192.00K derived: sum of 3 quarters · filed 2022-03-31 | $239.00K derived: sum of 4 quarters · filed 2022-03-31 |
| 2020-12-31 | -$1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $165.00K derived: sum of 2 quarters · filed 2022-03-31 | $212.00K derived: sum of 3 quarters · filed 2022-03-31 | $257.00K 10-K · filed 2022-03-31 |
| 2020-09-30 | $166.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | $213.00K derived: sum of 2 quarters · filed 2021-11-08 | $258.00K 10-Q · filed 2021-11-08 | |
| 2020-06-30 | $47.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | $92.00K 10-Q · filed 2021-08-16 | ||
| 2020-03-31 | $45.00K 10-Q · filed 2021-05-10 | |||
| 2019-12-31 | $252.00K 10-K · filed 2020-02-27 | |||
| 2018-12-31 | $67.00K 10-K · filed 2020-02-27 | |||
| 2017-12-31 | $81.00K 10-K · filed 2020-02-27 | |||
| 2016-12-31 | $10.00K 10-K · filed 2019-02-27 | |||
| 2015-12-31 | $157.00K 10-K · filed 2018-03-09 |